Naloxone hydrochloride reverses the potentially fatal respiratory depression caused by opioid overdose and has been used increasingly since 1996. In October 2010, the Harm Reduction Coalition emailed a survey to the 50 programs known to distribute naloxone. From 1996-June 2010, programs reported providing training and distributing naloxone to an estimated 53,032 people and received reports of 10,171 overdose reversals using naloxone. Twenty-one (43.7 percent) programs reported problems obtaining naloxone in the “past few months” before the survey.
Related Articles on Pain Management:
USA Pain Professionals Opens in New Mexico
Three-Quarters of Healthcare Facilities Report Success Treating Chronic Pain With Integrative Medicine
Senate Committee Hears Testimony on Pain in America
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.